Management of type 2 diabetes: A handbook for general practice

Preventing progression to type 2 diabetes

Download chapter

Last revised: 17 Sep 2020

Grade: A

People with impaired glucose tolerance (IGT) or impaired fasting glucose (IFG) should be referred to lifestyle intervention programs to:
  • achieve and maintain a 7% reduction in weight
  • increase moderate-intensity physical activity to at least 150 minutes per week

Grade: D, consensus

People with glycated haemoglobin (HbA1c) 6.0–6.4% may also benefit from a structured weight loss and exercise program to reduce their risk of developing type 2 diabetes

These recommendations are drawn from the most recent recommendations from organisations including the National Health and Medical Research Council (NHMRC), the Scottish Intercollegiate Guidelines Network (SIGN), Diabetes Canada, the American Diabetes Association (ADA) and other relevant sources. Refer to ‘Explanation and source of recommendations’ for explanations of the levels and grades of evidence.

Defining risk

Risk factors for type 2 diabetes include:3

  • demographic and social factors – age, family history, ethnicity
  • lifestyle factors – obesity, physical inactivity, smoking
  • clinical history – high blood pressure, high triglycerides and low high-density lipoprotein cholesterol (HDL-C), gestational diabetes, heart disease, stroke, depression, polycystic ovary syndrome, acanthosis nigrans and non-alcoholic fatty liver disease
  • medications – including corticosteroids and antipsychotic medications.

Clinicians should be alert to the possibility of type 2 diabetes in patients with these risk factors, many of which are also risk factors for cardiovascular disease (CVD).

The ‘metabolic syndrome’ (defined by the presence of at-risk measures for waist circumference, triglycerides, HDL-C, blood pressure and fasting glucose4) confers a three- to five-fold risk of type 2 diabetes as well as an increased risk for CVD.5

Patients with non-alcoholic fatty liver are at twice the risk of developing type 2 diabetes.6

Particular population groups are also at greater risk, such as people with Pacific Islander, Southern European or Asian backgrounds (refer to the discussion of ‘Who is at risk of type 2 diabetes?’ in the section ‘Defining and diagnosing type 2 diabetes’). Aboriginal and Torres Strait Islander peoples have more than three times the prevalence of type 2 diabetes compared with the wider population.7 Waist circumference has been found to be a strong predictor of the risk of developing type 2 diabetes, especially in Aboriginal women.8 Prevention programs that are culturally appropriate for Aboriginal and Torres Strait Islander peoples have been implemented successfully, although evidence for their effectiveness is limited – refer to Chapter 12 of The Royal Australian College of General Practitioners’ (RACGP’s) National guide to a preventive health assessment for Aboriginal and Torres Strait Islander people (3rd edition).

Other groups particularly at high risk of developing type 2 diabetes are people with impaired fasting glucose (IFG), impaired glucose tolerance (IGT) or gestational diabetes.9,10 Refer to the section ‘Defining and diagnosing type 2 diabetes’) for definitions of these states.

Progression to type 2 diabetes in people at high risk

About 5–10% of people at high risk develop diabetes annually.11 Three quarters of people with IFG or IGT will develop type 2 diabetes over their lifetime.12 People with IFG or IGT whose glucose metabolism returns to normal, either as a result of interventions or spontaneously, have roughly half the risk of developing type 2 diabetes compared with those who are persistently abnormal.13

Women with a history of gestational diabetes have approximately a seven-fold elevated risk of future development of type 2 diabetes.10,14–16

Evidence for lifestyle interventions to prevent type 2 diabetes

In randomised controlled trials, intensive lifestyle interventions have been shown to reduce the rates of progression to type 2 diabetes by 27–45% over periods ranging from 10 to 23 years.17 It remains unclear whether diabetes lifestyle intervention directly reduces complication-related morbidity and mortality.18

People at high risk of type 2 diabetes should also be offered lifestyle interventions to help them increase physical activity to at least 150 minutes per week, and to achieve and maintain a 7% reduction in weight. This may involve individual or group education and coaching.

In women with a history of gestational diabetes, beginning lifestyle interventions soon after pregnancy has been shown to reduce the incidence of type 2 diabetes by 25%.19

Other interventions

There is evidence that, in high-risk patients, metformin reduces the relative risk of developing type 2 diabetes by approximately 25%, and also reduces progression to renal and eye complications.20,21 However, metformin is not licensed by the Therapeutic Goods Administration for this use in Australia.

There have been no randomised controlled trials of the effect of bariatric surgery on preventing progression to type 2 diabetes.

Identifying people at high risk of type 2 diabetes

Identifying risk factors for type 2 diabetes is a routine part of general practice. The RACGP’s Guidelines for preventive activities in general practice (9th edition) recommend assessing body mass index (BMI), waist circumference, diet and physical activity in adults every two years. Screening for diabetes risk with the Australian type 2 diabetes risk assessment tool (AUSDRISK) is recommended in all adults aged ≥40 years every three years.22

Refer to the section ‘Defining and diagnosing type 2 diabetes’ for information about assessing diabetes risk and screening recommendations for diabetes, IFG and IGT.

Interventions to manage diabetes risk

Patients at high risk of type 2 diabetes are also at increased risk of cardiovascular disease. Their cardiovascular risk should thus be assessed, and lifestyle change and medications considered where appropriate.23 Refer to the section ‘Type 2 diabetes and cardiovascular risk’.

Particular lifestyle interventions have been shown to reduce the risk of type 2 diabetes in people with IGT, but not people with IFG alone. These interventions are of moderate intensity; for example, at least 16 sessions of 1–2 hours focusing on diet and physical activity delivered over six months by a range of health professionals. Patients should achieve at least 150 minutes per week of physical activity24 and a low-energy diet rich in fruit, vegetables and fibre, and low in meat and fat.

Maintaining lifestyle change, especially weight loss, in high-risk patients can be difficult. Technology-assisted modalities, including ‘apps’ that support change in diet and physical activity, activity trackers and websites providing information and referral options, are promising for helping people maintain physical activity and weight loss.25

Intensive lifestyle intervention may be beyond the scope of the brief interventions routinely delivered in general practice or practice nurse consultations, or even by those delivered through allied health visits as part of a care plan. Patients might therefore benefit from referral to a diabetes prevention program. A list of state-based diabetes prevention programs can be found on the Diabetes Australia website.

Telephone coaching programs run by state and territory governments and health insurance funds have also shown promising results.26

Refer to the RACGP’s Smoking, nutrition, alcohol, physical activity (SNAP) guide for more information.

  1. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care 2019;42(Suppl 1):S1–S194.
  2. Diabetes Canada Clinical Practice Guidelines Expert Committee. Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada. Can J Diabetes 2018;42(Suppl 1):S1–S325.
  3. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D’Agostino RB Sr. Prediction of incident diabetes mellitus in middle-aged adults: The Framingham Offspring Study. Arch Int Med 2007;167(10):1068–74.
  4. Alberti K, Eckel R, Grundy S, et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart Lunch and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120(16):1640–45.
  5. Shin J-A, Lee J-H, Lim S-Y, et al. Metabolic syndrome as a predictor of type 2 diabetes, and its clinical interpretations and usefulness. J Diabetes Investig 2013;4(4):334–43.
  6. Ballestri S, Zona S, Targher G, Dunstan DW, Brown A, Shaw JE. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta‐analysis. J Gastroenterol Hepatol 2016;31(5):936–44.
  7. Minges KE, Zimmet P, Magliano DJ, et al. Diabetes prevalence and determinants in Indigenous Australian populations: A systematic review. Diabetes Res Clin Pract 2011;93(2):139–49.
  8. Adegbija O, Hoy W, Wang Z. Predicting absolute risk of type 2 diabetes using age and waist circumference values in an aboriginal Australian community. PloS One 2015;10(4):e0123788.
  9. Nathan DM, Davidson MB, DeFronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care 2007;30(3):753–59.
  10. Bellamy L, Casas J-P, Hingorani AD, et al. Type 2 diabetes mellitus after gestational diabetes: A systematic review and meta-analysis. Lancet 2009;373(9677):1773–39.
  11. Gerstein HC, Santaguida P, Raina P, et al. Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: A systematic overview and meta-analysis of prospective studies. Diabetes Res Clin Pract 2007;78(3):305–12.
  12. Ligthart S, van Herpt TTW, Leening MJG, et al. Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: A prospective cohort study. Lancet Diabetes Endocrinol 2016;4(1):44–51.
  13. Perreault L, Pan Q, Mather KJ, et al. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: Results from the Diabetes Prevention Program Outcomes Study. Lancet 2012;379(9833):2243–51.
  14. Kramer CK, Campbell S, Retnakaran R. Gestational diabetes and the risk of cardiovascular disease in women: A systematic review and meta-analysis. Diabetologia 2019;62(6):905–14.
  15. Li J, Song C, Li C, Lui P, Sun Z, Yang X. Increased risk of cardiovascular disease in women with prior gestational diabetes: A systematic review and meta-analysis. Diabetes Res Clin Pract 2018;140:324–38.
  16. Song G, Wang C, Yang H-X. Diabetes management beyond pregnancy. Chin Med J (Engl) 2017;130(9):1009–11.
  17. American Diabetes Association. Standards of medical care in diabetes: 3. Prevention or delay of type 2 diabetes. Diabetes Care 2019;42(Suppl 1):S29–S33.
  18. Nathan D, Bennett P, Crandall J, et al. Does diabetes prevention translate into reduced long-term vascular complications of diabetes? Diabetologia 2019;62(8):1319–28.
  19. Goveia P, Cañon-Montañez W, Santos DP, et al. Lifestyle intervention for the prevention of diabetes in women with previous gestational diabetes mellitus: A systematic review and meta-analysis. Front Endocrinol (Lausanne) 2018;9:583.
  20. Barry E, Roberts S, Oke J, Vijayaraghavan S, Normansell R, Greenhalgh T. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: Systematic review and meta-analysis of screening tests and interventions. BMJ 2017;356:i6538.
  21. Aroda VR, Knowler WC, Crandall JP, et al. Metformin for diabetes prevention: Insights gained from the diabetes prevention program/diabetes prevention program outcomes study. Diabetologia 2017;60(9):1601–11.
  22. The Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 9th edition. East Melbourne, Vic: RACGP, 2016.
  23. DeFronzo RA, Abdul-Ghani M. Assessment and treatment of cardiovascular risk in prediabetes: Impaired glucose tolerance and impaired fasting glucose. Am J Cardiol 2011;108(3 Suppl):3B–24B.
  24. Smith AD, Crippa A, Woodcock J, Brage S. Physical activity and incident type 2 diabetes mellitus: A systematic review and dose–response meta-analysis of prospective cohort studies. Diabetologia 2016;59(12):2527–45.
  25. Bian RR, Piatt GA, Sen A, et al. The effect of technology-mediated diabetes prevention interventions on weight: A meta-analysis. J Med Internet Res 2017;19(3):e76.
  26. Cranney L, O’Hara B, Gale J, Rissel C, Bauman A, Phongsavan P. Telephone based coaching for adults at risk of diabetes: Impact of Australia’s Get Healthy Service. Transl Behav Med 2019;9(6):1178–85.